News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
585,576 Results
Type
Article (40945)
Company Profile (182)
Press Release (544449)
Section
Business (169019)
Career Advice (2429)
Deals (30489)
Drug Delivery (85)
Drug Development (74502)
Employer Resources (150)
FDA (14791)
Job Trends (13472)
News (294715)
Policy (28705)
Tag
Academia (2703)
Africa (767)
Alliances (43584)
Alzheimer's disease (1179)
Antibody-drug conjugate (ADC) (53)
Approvals (14718)
Arizona (105)
Artificial intelligence (69)
Asia (35836)
Australia (7022)
Bankruptcy (307)
Best Places to Work (10710)
Biotechnology (124)
C2C Services and Suppliers (63474)
California (1513)
Canada (824)
Cancer (374)
Career advice (2037)
Cell therapy (108)
China (122)
Clinical research (58229)
Collaboration (114)
Colorado (63)
Connecticut (62)
COVID-19 (2429)
Cystic fibrosis (64)
Data (190)
Diabetes (71)
Diagnostics (5845)
Drug pricing (66)
Earnings (59154)
Employer resources (133)
Europe (81222)
Events (84801)
Executive appointments (123)
FDA (14975)
Florida (226)
Funding (109)
Gene therapy (83)
Georgia (59)
GLP-1 (516)
Government (4212)
Healthcare (17735)
Hotbed/Location (392156)
Illinois (228)
Indiana (141)
Infectious disease (2452)
Inflammatory bowel disease (85)
Interviews (516)
IPO (13652)
Job creations (2855)
Job search strategy (1687)
Kansas (80)
Layoffs (376)
Legal (6127)
Liver cancer (55)
Lung cancer (91)
Manufacturing (67)
Maryland (346)
Massachusetts (1158)
Medical device (12562)
Medtech (12564)
Mergers & acquisitions (16696)
Metabolic disorders (230)
Michigan (113)
Minnesota (188)
Neuroscience (1319)
New Jersey (458)
New York (498)
NextGen Class of 2024 (6121)
Non-profit (4402)
North Carolina (553)
Northern California (700)
Obesity (135)
Ohio (96)
Opinion (184)
Patents (65)
Pennsylvania (471)
People (52907)
Phase I (17866)
Phase II (25634)
Phase III (19541)
Pipeline (100)
Postmarket research (2336)
Preclinical (7308)
Press Release (68)
Rare diseases (113)
Real estate (4866)
Recruiting (61)
Regulatory (19237)
Research institute (2340)
Resumes & cover letters (357)
South America (1055)
Southern California (619)
Startups (3144)
Texas (190)
United States (7056)
Vaccines (423)
Washington State (213)
Weight loss (123)
Date
Today (142)
Last 7 days (654)
Last 30 days (1946)
Last 365 days (35623)
2024 (24031)
2023 (37800)
2022 (48342)
2021 (52284)
2020 (50835)
2019 (44625)
2018 (33802)
2017 (30180)
2016 (28955)
2015 (33673)
2014 (25444)
2013 (20697)
2012 (22231)
2011 (23032)
2010 (20401)
585,576 Results for "dariohealth formerly known as labstyle innovations".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
DarioHealth Reports First Quarter 2024 Financial and Operating Results
DarioHealth Corp., a leader in the global digital health market, reported financial results for the first quarter 2024.
May 15, 2024
·
26 min read
Business
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 1st quarter ended March 31st, 2024, on Wednesday, May 15th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time.
May 7, 2024
·
2 min read
Business
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
DarioHealth Corp., a leader in the global digital health market, reported financial results for the fourth quarter 2023 and the full year 2023 and provided a corporate and commercial update.
March 28, 2024
·
27 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Business
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
DarioHealth Corp., a leader in the global digital health market, reported financial results for the third quarter 2023 and provided a corporate and commercial update.
November 2, 2023
·
21 min read
Pharm Country
DarioHealth to Host Investor Day on The Rise of Digital Health
DarioHealth Corp., a leader in the global digital health market, announced that it will host an in-person investor day in New York at the offices of Sullivan & Worcester LLP located at 1633 Broadway, 32nd floor, on October 17, 2023 at 11:00 AM ET.
October 3, 2023
·
4 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award
Theratechnologies Inc. today announced receipt of the 2023 Industrial Research Sectoral Group (RSRI) Innovation Award from the CQDM (formerly known as the Québec Consortium for Drug Discovery) and the Association for the Development of Research and Innovation of Québec (ADRIQ).
November 24, 2023
·
7 min read
Business
DarioHealth Reports Second Quarter 2023 Financial and Operating Results
DarioHealth Corp., a leader in the global digital health market, reported financial results for the second quarter 2023 and provided a corporate and commercial update.
August 10, 2023
·
25 min read
Drug Development
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate
Formerly known as AbGenomics Holding, AltruBio on Tuesday said it will use the funds to push its ulcerative colitis asset into a Phase IIb trial with an anticipated readout in 2026.
May 21, 2024
·
2 min read
·
Tyler Patchen
1 of 58,558
Next
